Global Cognitive and Memory Enhancer Drugs Market to Reach US$ 9,286.1 Million by 2032, Driven by Rise in Memory Disorders

September 29, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Cognitive and Memory Enhancer Drugs Market Report by Product (Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, and Others), Application (Disease Treatment, Athletic Performance, Academic Performance, and Others), and Region 2024-2032”, the global cognitive and memory enhancer drugs market size reached US$ 5,874.2 Million in 2023. Cognitive and memory enhancer drugs are a category of pharmaceuticals designed to improve cognitive function, memory, and mental agility. These drugs are targeted at individuals who are dealing with cognitive impairments or memory loss due to aging, neurological disorders, or other medical conditions. Characteristically, these drugs work by interacting with neurotransmitters in the brain to improve the speed of neural transmissions, boost focus, and enhance memory retention. They can vary widely in their chemical compositions, mechanisms of action, and efficacy, but the ultimate aim is to improve quality of life by enhancing cognitive abilities. The notable features of these drugs include their ability to modulate synaptic plasticity, which is crucial for memory formation and learning. They also possess neuroprotective properties, helping to shield brain cells from damage and slow down the progression of cognitive decline. Some of these drugs have been shown to improve attention span and problem-solving abilities. Cognitive and memory enhancer drugs find their application in the healthcare and pharmaceuticals, military and defense, sport and athletics, mental health institutions, geriatric care centers, veterinary medicine, and academia and research.

Global Cognitive and Memory Enhancer Drugs Market Trends:

The increase in aging population represents one of the key factors driving the market growth. Moreover, the rising awareness of cognitive and memory-related disorders due to educational campaigns and media coverage, is a major growth inducing factor. In addition to this, innovations in drug formulation, coupled with the advancements in diagnostic techniques are propelling the growth of the market. Besides this, the stigma surrounding mental health is gradually decreasing which, in turn, is contributing to the market growth. Along with this, favorable government policies and regulations are making it easier for these drugs to be approved and distributed, thereby supporting the market growth. Apart from this, the modern lifestyle is leading to increased stress and anxiety, which are linked to cognitive issues, thus fostering the market growth of cognitive and memory enhancer drugs. Coupled with this, the rising academic pressures are also leading students to seek cognitive enhancers to improve academic performance. Additionally, the increased access to global markets is allowing pharmaceutical companies to tap into previously unreachable markets, thereby facilitating the market growth. Furthermore, the shift in consumer preference towards preventive healthcare is creating a positive outlook for the market. Other factors such as higher disposable income in emerging economies, clinical trials, insurance coverage, and telemedicine are driving the growth of the market across the globe. Looking forward, the market value is projected to reach US$ 9,286.1 Million by 2032, expanding at a CAGR of 5.06% during 2024-2032.

Market Summary:

  • On the basis of the product, the market is segmented into Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, and others. Currently, Aricept holds the largest market share.
  • On the basis of the application, the market is segregated into disease treatment, athletic performance, academic performance, and others. At present, disease treatment accounts for the largest market share.
  • Region wise, the market is divided into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. Currently, North America represents the leading market.
  • The competitive landscape of the industry has also been examined, with some of the key players being AbbVie Inc., Biogen Inc., Eisai Co Ltd., Novartis AG and Takeda Pharmaceutical Company Ltd.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment: 
  • Product
  • Application
  • Region
Products Covered Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, Others
Applications Covered Disease Treatment, Athletic Performance, Academic Performance, Others
Regions Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered AbbVie Inc., Biogen Inc., Eisai Co Ltd., Novartis AG, Takeda Pharmaceutical Company Ltd., etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Cognitive and Memory Enhancer Drugs Market to Reach US$ 9,286.1 Million by 2032, Driven by Rise in Memory Disorders
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More